Cough, Cold and Allergy (Hay Fever) Remedies in France
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FRANCE
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
New Studies and New Regulations
Brands Must Create New Strategies To Make Their Products Relevant All Year Round
Distribution Shifts Are Expected
Competitive Landscape
Sanofi Gains Ground
Antihistamines and Pharyngeal Preparations: Two Very Different Categories
Category Data
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2013-2018
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2013-2018
Table 3 Sales of Decongestants by Category: Value 2013-2018
Table 4 Sales of Decongestants by Category: % Value Growth 2013-2018
Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2018
Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2015-2018
Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2018-2023
Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2018-2023
Executive Summary
Stagnation for Self-medication
Boom of Sleep Aids, Sports Nutrition, Vitamins and Dietary Supplements
Innovation Is Key To Success
Consumers' Trust in Chemists/pharmacies Is Strong
Future Sales Look Promising Overall But Only Certain Categories Will Grow
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 10 Life Expectancy at Birth 2013-2018
Market Data
Table 11 Sales of Consumer Health by Category: Value 2013-2018
Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Sources
Summary 2 Research Sources
In 2017 and 2018, various scientific organisations stated that many products claiming to combat colds and flu are inefficient and sometimes even risky, leading for instance to heart problems. This drove the French National Agency for Medicines and Health Products Safety to prohibit manufacturers from conducting advertising campaigns aimed at the general public in December 2017. In this perspective, there is even a plan for new labelling rules to eliminate branding, such as neutral packaging. Ini...
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.